32
Total investments
18
Early stage
8
Mid stage
2
Late stage
5y
Years active
Portfolio
31 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Feb 2026
World Labs is a spatial intelligence company building Large World Models (LWMs) to perceive, generate, and interact with the 3D world. We aim to lift AI models from the 2D plane of pixels to full 3D worlds – both virtual and real – endowing them with spatial intelligence as rich as our own.
We believe that humans are innovative, curious, and creative; science and technology are both manifestations and drivers of these impulses. Propelling AI forward with spatial intelligence will also propel forward both individuals and humanity as a whole. Toward this goal, World Labs will develop spatially intelligent LWMs that can understand and reason about the 3D world from images and other modalities. Over time, we expect to train increasingly powerful models with broader capabilities that can be applied in a variety of domains, working alongside people.
These are ambitious goals, so we are building an ambitious company to tackle them. Our team, led by co-founders Fei-Fei Li, PhD; Justin Johnson, PhD; Christoph Lassner, PhD; and Ben Mildenhall, PhD, has a strong research background, but we are not motivated by exploration for its own sake. Instead, we believe that now is a unique moment where rapid scientific progress has thinned the barrier between research and applications. We aim to seize this opportunity, focusing on the entire throughline from research to engineering to product to people.
We are bringing together the most formidable slate of pixel talent ever assembled, creating a tight feedback loop between our spatially intelligent foundation models and products that will empower our users. We invite you to learn more about joining our fast-growing team.
Investor
Apr 2024
We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.
Investor
Apr 2024
Arintra provides the industry’s leading GenAI-native autonomous coding platform, enabling health systems to get paid accurately and efficiently for the care they deliver, driving revenue assurance at scale. By combining cutting-edge AI with deep clinical expertise, Arintra autonomously codes charts with high accuracy, without human intervention. Unlike bolt-on tools, Arintra works directly within the EHR, ensuring seamless adoption with zero workflow changes or data integrity risk. Health systems use Arintra to unlock missed revenue due to coding gaps, documentation issues, and unchallenged denials - achieving 5%+ uplift in revenue, 12%+ reduction in A/R days, and 43%+ fewer denials.
Investor
Sep 2023
Solve Intelligence is the leading AI patent solution for IP teams and legal professionals globally.
Over 400 IP teams across 6 continents use Solve Intelligence’s AI patent software for patent application drafting, prosecution, claim charts, and invention harvesting.
Backed by leading investors including Y Combinator, Thomson Reuters, Microsoft, 20VC and Visionaries, Solve Intelligence has raised a total of $55m in funding to build the world’s leading AI patent tools to support the end-to-end workflows of IP teams and legal professionals.
Our goal is simple: if it touches patents, you should be able to do it faster, better, and more collaboratively in Solve Intelligence.
With a growing team of world-leading engineers and patent attorneys, Solve Intelligence is actively hiring across a number of roles: https://www.ycombinator.com/companies/solve-intelligence/jobs
If you are a patent practitioner, we would love to hear from you: https://www.solveintelligence.com/contact-us
Investor
Jul 2023
Building the worlds largest immune databank to inform therapy and develop diagnostics through a convergence of high-resolution immune cell sequencing and artificial intelligence.
We bring together bright minds from multiple disciplines. We are driven to shorten the timeline from research to real-world human impact. Our motivation is to put science in service of humanity.
Join us in our mission: Healthcare for everyone, everywhere.
Science is we all.
Investor
Jul 2023
Jericho Security is on a mission to defend the world from the new threats of generative AI cyber attacks. We created our proprietary generative AI, CyberGPT, to simulate attacks, create new defenses and educate your teams about how to prevent serious losses from cyberattacks.
With unparalleled expertise in sophisticated analytics and top-of-the-line educational frameworks, we are committed to defending others from the unimaginable scale and volume of attacks that only AI can unleash.
Investor
Apr 2023
Build LLM Apps in minutes, not days. Berri lets you easily connect your data and build production-ready LLM apps in minutes.
Investor
Mar 2023
Zafrens is a therapeutics company pioneering an ultra-high throughput platform to isolate, culture, image, and sequence millions of cells per day. The proprietary platform allows for full characterization of diverse cell populations, as well as directly correlating molecular profiles (DNA, RNA, protein) to cell phenotype and function. The company’s mission is to unlock the full story of every cell to accelerate drug discovery.
Investor
Sep 2022
We get you the right insurance, so youre better protected & save money.
Millions of people bought insurance in a rush a decade ago as their home closed, or when their landlord asked for a renters policy, or when the dealership needed proof of insurance for a new car. A lot of people just bought something as quickly as they could, for the first price they got quoted. But, it turns out the coverage isnt always appropriate for you. Shopping around for insurance is a chore, made worse because people dont know what coverages they need, and the industrys tendency to upsell.
Coverage Cat focuses on getting you the set of policies you need, the right amount of coverage, so youre guarded from catastrophe at the best price.
Investor
Sep 2022
Bitstacks mission is to empower people to participate in a more open financial system.
Bitstack has gone from a simple product that turns your spare change into bitcoin to a bitcoin-native neobank that is bringing a better way to buy, sell, earn and spend bitcoin.
Bitstack is powered by Bitcoin - the first open, global, and permissionless monetary network that allows users to send and receive money anywhere, instantly, with almost no fees, and with no central issuer that can debase its currency.
Investor
Sep 2022
Building AI workforce through AI workflows for startups and enterprises. Feel free to reach out to us for more info
Investor
Sep 2022
Tranch, an Elite company, is the invoice to payments platform for law firms to get paid faster through invoice automation and frictionless payments. Tranch’s suite of products enables firms to get started with no-code payment options to fully-integrated ERP billing solutions. Tranch was founded in 2021 and is based out of New York and London. Visit tranch.com to learn more.
Investor
Sep 2022
Momentu is an emotional wellness platform for Latin America.
We are democratizing mental health access
Investor
Aug 2022
At Ownerific we’re building the leading marketplace for aspiring homeowners. Our users earn money and get on the path to homeownership! We offer High Yield Savings, Partnership Offers, and a Housing Marketplace, making Ownerific a comprehensive financial wellness hub.
Founded in 2022, by experienced unicorn founders and real estate investors, Ownerific is at the forefront of fintech housing solutions. Headquartered in Washington, DC, were a highly motivated and experienced team working in a hybrid environment. As a venture-funded, growth-focused startup, we’ve quickly raised a seed round and are looking to deliver the Beta platform to our first clients in the coming months.
Show all 31 investments ↓
Experience · 35 entries
All (35)
Investments (32)
2026
Investor
Feb 2026
World Labs is a spatial intelligence company building Large World Models (LWMs) to perceive, generate, and interact with the 3D world. We aim to lift AI models from the 2D plane of pixels to full 3D worlds – both virtual and real – endowing them with spatial intelligence as rich as our own.
We believe that humans are innovative, curious, and creative; science and technology are both manifestations and drivers of these impulses. Propelling AI forward with spatial intelligence will also propel forward both individuals and humanity as a whole. Toward this goal, World Labs will develop spatially intelligent LWMs that can understand and reason about the 3D world from images and other modalities. Over time, we expect to train increasingly powerful models with broader capabilities that can be applied in a variety of domains, working alongside people.
These are ambitious goals, so we are building an ambitious company to tackle them. Our team, led by co-founders Fei-Fei Li, PhD; Justin Johnson, PhD; Christoph Lassner, PhD; and Ben Mildenhall, PhD, has a strong research background, but we are not motivated by exploration for its own sake. Instead, we believe that now is a unique moment where rapid scientific progress has thinned the barrier between research and applications. We aim to seize this opportunity, focusing on the entire throughline from research to engineering to product to people.
We are bringing together the most formidable slate of pixel talent ever assembled, creating a tight feedback loop between our spatially intelligent foundation models and products that will empower our users. We invite you to learn more about joining our fast-growing team.
2024
Investor
Apr 2024
We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.
Investor
Apr 2024
Arintra provides the industry’s leading GenAI-native autonomous coding platform, enabling health systems to get paid accurately and efficiently for the care they deliver, driving revenue assurance at scale. By combining cutting-edge AI with deep clinical expertise, Arintra autonomously codes charts with high accuracy, without human intervention. Unlike bolt-on tools, Arintra works directly within the EHR, ensuring seamless adoption with zero workflow changes or data integrity risk. Health systems use Arintra to unlock missed revenue due to coding gaps, documentation issues, and unchallenged denials - achieving 5%+ uplift in revenue, 12%+ reduction in A/R days, and 43%+ fewer denials.
2023
Investor
Sep 2023
Solve Intelligence is the leading AI patent solution for IP teams and legal professionals globally.
Over 400 IP teams across 6 continents use Solve Intelligence’s AI patent software for patent application drafting, prosecution, claim charts, and invention harvesting.
Backed by leading investors including Y Combinator, Thomson Reuters, Microsoft, 20VC and Visionaries, Solve Intelligence has raised a total of $55m in funding to build the world’s leading AI patent tools to support the end-to-end workflows of IP teams and legal professionals.
Our goal is simple: if it touches patents, you should be able to do it faster, better, and more collaboratively in Solve Intelligence.
With a growing team of world-leading engineers and patent attorneys, Solve Intelligence is actively hiring across a number of roles: https://www.ycombinator.com/companies/solve-intelligence/jobs
If you are a patent practitioner, we would love to hear from you: https://www.solveintelligence.com/contact-us
Show all 35 entries ↓
Investment activity
2021–2026 · 32 investments
Recent (last 2 years)Earlier
